Roles of αsynuclein in gastrointestinal microbiome dysbiosisrelated Parkinson's disease progression (Review).
Reads0
Chats0
TLDR
In this article, the abnormal accumulation of α-synuclein (α-syn) in the intestine caused by changes to the gastrointestinal microbiome (GM) caused misfolding and abnormal aggregation of α−syn in the intestines, leading to the formation of eosinophilic Lewis bodies in the cytoplasm and mitochondrial dysfunction in dopaminergic (DA) neurons.Abstract:
Parkinson's disease (PD) is the second most common neurodegenerative disease amongst the middle‑aged and elderly populations. Several studies have confirmed that the microbiota‑gut‑brain axis (MGBA) serves a key role in the pathogenesis of PD. Changes to the gastrointestinal microbiome (GM) cause misfolding and abnormal aggregation of α‑synuclein (α‑syn) in the intestine. Abnormal α‑syn is not eliminated via physiological mechanisms and is transported into the central nervous system (CNS) via the vagus nerve. The abnormal levels of α‑syn aggregate in the substantia nigra pars compacta, not only leading to the formation of eosinophilic Lewis Bodies in the cytoplasm and mitochondrial dysfunction in dopaminergic (DA) neurons, but also leading to the stimulation of an inflammatory response in the microglia. These pathological changes result in an increase in oxidative stress (OS), which triggers nerve cell apoptosis, a characteristic of PD. This increase in OS further oxidizes and intensifies abnormal aggregation of α‑syn, eventually forming a positive feedback loop. The present review discusses the abnormal accumulation of α‑syn in the intestine caused by the GM changes and the increased levels of α‑syn transport to the CNS via the MGBA, resulting in the loss of DA neurons and an increase in the inflammatory response of microglial cells in the brain of patients with PD. In addition, relevant clinical therapeutic strategies for improving the GM and reducing α‑syn accumulation to relieve the symptoms and progression of PD are described.read more
Citations
More filters
Journal ArticleDOI
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
TL;DR: The hypothesis that Parkinson’s disease could begin in the gut is supported, with a focus on how food-based therapies might then have an influence on PD and could ameliorate non-motor as well as motor symptoms.
Journal ArticleDOI
Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis
Júlio César Claudino dos Santos,Micael Porto Portela Lima,Gerly Anne de Castro Brito,Glauce Socorro de Barros Viana +3 more
TL;DR: In this article , the authors discuss how the microbiota-gut-brain axis and environmental influences interact with the immune system to promote a pro-inflammatory state that is involved in the initiation and progression of misfolded α-synuclein proteins and the beginning of the early non-motor symptoms of Parkinson's disease.
Journal ArticleDOI
Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease
Tiantian Li,Chuanqi Chu,Leilei Yu,Qixiao Zhai,Shunhe Wang,Jianxin Zhao,Hao Zhang,Wei Jiong Chen,Fengwei Tian +8 more
TL;DR: In this paper , the effects of probiotic Bifidobacterium breve CCFM1067, administered for 5 weeks in a Parkinson's disease (PD) mouse model, were examined.
Journal ArticleDOI
Bacillus amyloliquifaciens-Supplemented Camel Milk Suppresses Neuroinflammation of Autoimmune Encephalomyelitis in a Mouse Model by Regulating Inflammatory Markers
TL;DR: In this paper , Bacillus amyloliquefaciens-supplemented camel milk (BASY) was used to assess its preventive effect on MS symptoms in a myelin oligodendrocyte glycoprotein (MOG)-immunized C57BL6J mice model.
Journal ArticleDOI
METTL14 is decreased and regulates m6A modification of α‐synuclein in Parkinson's disease
Honghu He,Qinxin Zhang,Jiajia Liao,Jiang Lei,Man Luo,Jian-feng Huang,Mei-Ling Chen,Yuefei Shen,Jing Wang,Pingyi Xu,Yousheng Xiao +10 more
TL;DR: In this article , the role of m6A modification and its underlying mechanism in Parkinson's disease was investigated and the potential of METTL14 as a novel diagnostic biomarker for PD was revealed.
References
More filters
Journal ArticleDOI
Probiotics for Constipation in Parkinson Disease: A Randomized Placebo-Controlled Study.
Ai Huey Tan,Shen-Yang Lim,Kah Kian Chong,Mohammad Addin Azhan A Manap,Jia Wei Hor,Jia Lun Lim,Soon Chai Low,Chun Wie Chong,Sanjiv Mahadeva,Anthony E. Lang +9 more
TL;DR: This study provides Class I evidence that for people with PD, multi-strain probiotics significantly increased the average number of spontaneous bowel movements per week and significant improvements were seen for secondary outcomes after correction for multiple comparisons.
Journal ArticleDOI
Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans
María Eugenia Goya,Feng Xue,Cristina Sampedro-Torres-Quevedo,Sofia Arnaouteli,Lourdes Riquelme-Dominguez,Andrés Romanowski,Jack Brydon,Kathryn L. Ball,Nicola R. Stanley-Wall,Maria Doitsidou +9 more
TL;DR: The Bacillus subtilis probiotic strain PXN21 inhibits α-synuclein aggregation and clears preformed aggregates in an established Caenorhabditis elegans model of synucleinopathy, and functional roles of the sphingolipid metabolism genes lagr-1, asm-3, and sptl-3 in the anti-aggregation effect are demonstrated.
Journal ArticleDOI
Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants
Cintia Roodveldt,Adahir Labrador-Garrido,Elena Gonzalez-Rey,Rafael Fernandez-Montesinos,Marta Caro,Christian Claude Lachaud,Christopher A. Waudby,Christopher A. Waudby,Mario Delgado,Christopher M. Dobson,David Pozo +10 more
TL;DR: Findings might contribute to explain the differences in the onset and progression of this highly debilitating disease, which could be of value in the development of rational approaches towards effective control of immune responses that are associated with PD.
Journal ArticleDOI
Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production
Victor Tapias,Xiaoping Hu,Kelvin C. Luk,Laurie H. Sanders,Virginia M.-Y. Lee,J. Timothy Greenamyre +5 more
TL;DR: Many of the harmful effects found were more prominent in DA rather than non-DA neurons, suggestive of higher susceptibility to degenerate and could represent a novel and valuable model to study DA-related neurodegeneration.
Journal ArticleDOI
Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture : Relevance to Parkinson's disease
TL;DR: The results suggest that reactive microglias could induce oxidative stress in dopaminergic neurons and such oxidative stress may finally lead to nitration of alpha-synuclein and death of dopamine neurons in PD.